Company Filing History:
Years Active: 2006-2010
Title: Innovations by Nilabh Shastri
Introduction
Nilabh Shastri is a prominent inventor based in Richmond, CA (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of prostate cancer. With a total of 3 patents to his name, Shastri's work has the potential to impact the medical community profoundly.
Latest Patents
One of his latest patents focuses on the diagnosis of prostate cancer using the SPAS-1 cancer antigen. This patent discloses compounds and methods for inducing protective immunity against cancer. The compounds include polypeptides that contain at least one immunogenic portion of one or more SPAS-1 proteins, along with DNA molecules encoding such polypeptides. These compounds can be formulated into vaccines and pharmaceutical compositions for immunization against cancer or used for the diagnosis and monitoring of cancer progression.
Another significant patent by Shastri involves ERAAP modulators that regulate immune responses. This method selectively inhibits ERAAP, which is associated with antigen processing, to modulate immune responses. The process includes contacting a patient in need of immune response modulation with a physiologically acceptable dosage composition that contains an effective amount of an inhibitor of ERAAP activity. The effectiveness of various selective inhibitors, including amino thiols and ERAAP-specific siRNA, is demonstrated in this patent.
Career Highlights
Nilabh Shastri is affiliated with the University of California, where he continues to advance his research in immunology and cancer treatment. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of immune responses in cancer.
Collaborations
Shastri has collaborated with notable colleagues, including Thomas Serwold and James Patrick Allison, who have also made significant contributions to the field of cancer research.
Conclusion
Nilabh Shastri's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer. His patents reflect a commitment to developing effective diagnostic and therapeutic strategies that could change the landscape of cancer treatment.